Form 8-K AMAG PHARMACEUTICALS For: Nov 02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
AMAG Pharma (AMAG) Reports Q3 Loss of $4.31/Share
November 2, 2017 7:17 AM EDTAMAG Pharma (NASDAQ: AMAG) reported Q3 EPS of ($4.31), may not compare to the analyst estimate of $0.18. Revenue for the quarter came in at $153.7 million versus the consensus estimate of $168.69 million.
GUIDANCE:
AMAG Pharma sees FY2017 revenue of $596-628 million, versus the... More
